| 2024 | 2023 | 2022 | 2021 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross margin | 15,2 k € | +82.7% | 8,3 k € | -38.3% | 13,5 k € | +30.0% | 10,4 k € | -4.4% | 10,8 k € | -15.5% | 12,8 k € | -56.7% | 29,6 k € | +0.6% | 29,4 k € | +23024.1% | 127,0 € | -99.9% | 227,0 k € | +1199.9% | -20,6 k € | -252.3% | -5,9 k € | -129.4% | 20,0 k € | +324.1% | -8,9 k € | -120.9% | 42,6 k € | +80.1% | 23,6 k € | -64.1% | 65,8 k € | -39.1% | 108,1 k € | |
| EBITDA | 12,5 k € | +117.0% | 5,8 k € | -48.2% | 11,2 k € | +38.0% | 8,1 k € | +0.7% | 8,0 k € | -22.0% | 10,3 k € | -62.0% | 27,1 k € | +1.6% | 26,7 k € | +392.2% | -9,1 k € | -105.5% | 164,5 k € | +750.8% | -25,3 k € | -177.4% | -9,1 k € | -155.4% | 16,4 k € | +244.5% | -11,4 k € | -128.6% | 39,7 k € | +389.7% | -13,7 k € | -164.1% | 21,4 k € | -35.2% | 33,0 k € | |
| Operating profit | -5,1 k € | +59.3% | -12,5 k € | -75.3% | -7,1 k € | +30.1% | -10,2 k € | +0.5% | -10,3 k € | -21.2% | -8,5 k € | -221.1% | 7,0 k € | +136.2% | -19,3 k € | +16.8% | -23,2 k € | -115.5% | 150,4 k € | +450.6% | -42,9 k € | -83.6% | -23,4 k € | -1770.3% | 1,4 k € | +105.2% | -26,8 k € | -199.5% | 26,9 k € | +196.2% | -28,0 k € | -538.1% | 6,4 k € | +164.4% | -9,9 k € | |
| Profit/loss | -3,7 k € | +63.9% | -10,2 k € | -77.8% | -5,8 k € | +28.0% | -8,0 k € | -13.2% | -7,1 k € | -33.6% | -5,3 k € | -148.7% | 10,8 k € | +169.6% | -15,6 k € | +27.6% | -21,5 k € | -116.7% | 128,3 k € | -41.7% | 219,9 k € | +1041.6% | -23,4 k € | -1216.2% | 2,1 k € | +108.2% | -25,7 k € | -195.8% | 26,8 k € | +189.4% | -30,0 k € | -221.0% | 24,8 k € | +225.5% | -19,7 k € | |
| Equity | 319,1 k € | -1.1% | 322,8 k € | -3.1% | 333,0 k € | -1.7% | 338,8 k € | +1.4% | 334,1 k € | -2.1% | 341,2 k € | +2.7% | 332,0 k € | +3.4% | 321,2 k € | -4.6% | 336,8 k € | -6.0% | 358,2 k € | +55.8% | 229,9 k € | +2204.7% | 10,0 k € | -70.1% | 33,3 k € | +6.7% | 31,2 k € | -45.1% | 56,9 k € | +88.9% | 30,1 k € | -49.9% | 60,1 k € | +70.2% | 35,3 k € | |
| Total assets | 945,4 k € | -0.8% | 952,5 k € | -2.2% | 974,2 k € | -1.2% | 985,5 k € | -2.0% | 1,0 M € | -0.9% | 1,0 M € | -0.9% | 1,0 M € | -2.1% | 1,0 M € | +7.0% | 977,2 k € | -20.7% | 1,2 M € | +84.7% | 667,4 k € | +279.5% | 175,8 k € | -7.0% | 189,0 k € | +2.2% | 185,0 k € | -23.5% | 241,9 k € | +20.1% | 201,3 k € | -19.7% | 250,6 k € | -35.5% | 388,5 k € | |
| Cash | 5,1 k € | +12.3% | 4,5 k € | -18.8% | 5,6 k € | -53.8% | 12,1 k € | -65.1% | 34,6 k € | +42.9% | 24,2 k € | +59.5% | 15,2 k € | +606.7% | 2,1 k € | -97.7% | 91,6 k € | +1512.1% | 5,7 k € | -97.2% | 204,8 k € | +27753.7% | 735,2 € | +14.3% | 643,2 € | -29.7% | 914,3 € | -95.8% | 21,5 k € | +291.3% | 5,5 k € | +652.1% | 732,0 € | -53.5% | 1,6 k € | |
| Debts | 564,0 k € | -0.1% | 564,7 k € | -1.5% | 573,3 k € | -0.5% | 576,2 k € | -0.9% | 581,5 k € | +0.2% | 580,1 k € | -0.1% | 580,5 k € | -0.6% | 584,2 k € | +29.5% | 451,2 k € | -30.8% | 651,9 k € | +108.3% | 313,0 k € | +88.7% | 165,9 k € | +6.5% | 155,7 k € | +1.3% | 153,7 k € | -16.9% | 184,9 k € | +8.0% | 171,2 k € | -10.1% | 190,5 k € | -46.1% | 353,1 k € | |
| Staff | — | — | — | — | — | — | — | — | 0,2 | 1,3 | 0,1 | — | — | — | — | 1,4 | 1 | 1,7 | ||||||||||||||||||
Private limited company · Damme · incorporated on 05/04/1988
Private limited company loss-making in the latest fiscal year. Cash position rising (+12.3%).
Acceptable counterparty for a moderate engagement. Require 2 fiscal years of detailed accounts before any significant exposure. The abridged model hides revenue.
BIOCONTROL is a Private limited company incorporated in 1988. Its main activity is: Research and experimental development on natural sciences and engineering. Its registered office is in Damme.
Key indicators
7-day free trial, no credit card required.
7-day free trial, no credit card required.
7-day free trial, no credit card required.
Source: Belgian Official Gazette